Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
All > Germany >

Deals > Western Germany

Find below deals from the Western German Federal States of Hessen, Nordrhein-Westfalen, Rheinland-Pfalz and Saarland. Listed are news deals for this region as well as from organisations located there.

Total search results: 1334 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Deutsche Bank: investor conference, 201906 supply service Evotec presents at dbAccess Berlin Conference 2019-06-05
Helmholtz–Bruker Corp: mass spectrometry software 2019-05-31
Helmholtz–Bruker Corp: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w 2019-05-31
Inovio–Qiagen: molecular companion diagnostics, 201905– collab developm of CDx for VGX-3100 DNA-based immunotherapy for cervical dysplasia 2019-05-16
Navan Technologies–High-Tech Gründerfonds: investment, 201905 seed financing round incl Amgen Ventures + HTGF + Hemi Ventures et al 2019-05-15
Priavoid–PERSON: investment, 201905c Detlev Riesner recently acquired shares of Priavoid GmbH 2019-05-10
MabVax Therapeutics–BioNTech: investment, 201905 acquisition €na of antibody assets + infrastructure + lab equipment in San Diego 2019-05-08
DyNAbind–High-Tech Gründerfonds: investment, 201905 seed financing round incl new investor HTGF 2019-05-07
Merck (DE)–DyNAbind: drug discovery technology, 201905 collab existent marketing of DEL discovery kit with Merck KGaA 2019-05-07
Amal Therapeutics–Boehringer: cancer drugs, 201905– collab clinical research combi study of ATP128 + BI754091 in colorectal cancer 2019-05-02
miRdetect–High-Tech Gründerfonds: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
InfanDx–Arnika Beteiligungen: investment, 201904 financing round totalling up to €5.3m incl existing + co-investor Arnika Beteiligungen GmbH 2019-04-24
InfanDx–CVG Capital: investment, 201904 financing round totalling up to €5.3m incl new investor CVG Capital GmbH 2019-04-24
InfanDx–Life Science Inkubator: investment, 201904 financing round totalling up to €5.3m incl existing + co-investor LSI-Pre-Seed-Fonds GmbH 2019-04-24
InfanDx–SEVERAL: investment, 201904 financing round up to €5.3m milestone-based from Bamed MAM + CVG Capital + LSI PreSeed + Arnika Beteiligungen 2019-04-24
Boehringer–PureTech Health: cancer immunotherapy, 201904– colllab research up to $226m + royalties using lymphatic targeting platform for I-O drugs 2019-04-17
Cevec–SEVERAL: investment, 201904 financing round Series D from new + existing investors 2019-04-16
Phenex–Helmholtz: drug research, 201904– collab joint research in NASH + liver cancer metabolism with Heikenwälder Group at DKFZ 2019-04-05
AgomAb Therapeutics–Boehringer: investment, 201904 financing round Series A totalling €21m incl co-investor BIVF 2019-04-03
LabCorp–Qiagen: molecular companion diagnostics, 201904– collab LabCorp joins Qiagen’s Day-One Lab Readiness program 2019-04-03
Bayer–ProteoNic: rec protein production technology, 201903– license non-excl €na to use 2G UNic technology to boost rec protein production 2019-03-28
Cytena–High-Tech Gründerfonds: investment, 201903 financing round Series A totalling €3.m incl HTGF + two private investors 2019-03-26
Protagen–Oncimmune: investment, 201903 acquisition of Portagen for up to £4.11m in up to 2.636m ordinary shares 2019-03-19
Merck (DE)–Iktos: drug discovery services, 201903– collab using AI technology for small molecule drug discovery projects 2019-03-14
Versum Materials–Merck (DE): investment, 201902– unsolicited all-cash offer at $48/share by Merck 2019-02-27
Alchemist Accelerator–BASF: investment, 201902 BASF Venture Capital invests $2m + becomes Limited Partner 2019-02-20
Plasmion–High-Tech Gründerfonds: investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel 2019-02-14
Macherey-Nagel–Andrew Alliance: automated liquid handling technology, 201902–collab co-marketing NucleoBond kits with OneLab s/w + Andrew+ robot 2019-02-04
United Kingdom (govt)–Qiagen: bioinformatics, 201902– supply Genomics England selects QCI for genome sequencing project of NHS 2019-02-04
MAB Discovery–BioNTech: investment, 201901–201903 acquisition €na of Antibody Generation Unit of MAB Discovery by BioNTech 2019-01-23
Miltenyi Biotec–Univ Duisburg-Essen: imaging technology, 201901 acquisition process for opitcal clearing of biological samples for miccrosopy 2019-01-17
Mecuris–High-Tech Gründerfonds: investment, 201901 financing round Series A totalling €3.6m incl existing investor HTGF 2019-01-16
Boehringer–Bioharmony Therapeutics: antibiotics, 201901– collab developm of bateriophage lysins 2019-01-15
Atriva Therapeutics–High-Tech Gründerfonds: investment, 201901 financing round Series A first closing led by Meneldor + HTGF 2019-01-03
PreOmics–High-Tech Gründerfonds: investment, 201812 financing round Series A totalling €3.3m incl HTGF + Think.Health Ventures + business angels 2018-12-18
DenovoMatrix–High-Tech Gründerfonds: investment, 201812 seed financing round from HTGF + TGFS 2018-12-11
genOway–Merck (DE): CRISPR technology, 201812– collab strategic alliance €na incl ww excl license to produce + sell genome-edited rodent models 2018-12-10
Merck (DE)–Cyclica: drug discovery services, 201812– collab using cloud-based proteome screening platform for small molecule drug development 2018-12-06
Anagenesis–Boehringer: investment, 201812 financing round Series A 1st closing totalling €3m incl new investor BIVF 2018-12-04
Boehringer–Domain Therapeutics: drug discovery services, 201812– collab + license agreem €na discovery of GPCR-targeting CNS drugs 2018-12-04
Bayer–Cyclica: drug discovery services, 201811– collab using cloud-based proteome screening platform for small molecule drug development 2018-11-26
Suntory–BRAIN: food ingredients, 201811– collab €na developm natural beverage solutions with SBFE 2018-11-26
Boehringer–Epizyme: small-molecule cancer drugs, 201811– collab strategic ww to develop inhibitors toward two epigenetic targets 2018-11-15
BioNTech–Univ Pennsylvania: mRNA technology, 201811– strategic research collab €na to develop mRNA vaccines for infectious disease 2018-11-05
Grünenthal–AstraZeneca: esomeprazole, 201810– acquisition $922m of European rights to Nexium + ww ex US+JP rights to Vimovo 2018-10-30
Noscendo–SEVERAL: investment, 201810 financing round €7-digit led by Wieland Capital + incl HTGF + three business angels 2018-10-29
BASF–MIT: CRISPR technology, 201810– license ww non-excl to CRISPR-Cpf1 technology from Broad Institute for agriculture + industrial microbiology 2018-10-24
Genome Biologics (DE)–EU (govt): grant, 201810 Horizon 2020 Phase 2 Grant €2.42m 2018-10-22
LaVision BioTec–Miltenyi Biotec: investment, 201810 acquisition of LaVision BioTec GmbH by Miltenyi 2018-10-12
Lipoid–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Lipoid GmbH 2018-10-08
Strüngmann Group–Cyclenium: anti-infectives, 201810– collab discovery using CMRT technology + QUEST Library with AiCuris 2018-10-01
Pfizer–Qiagen: companion diagnostics, 201809 collab existent CDx for precision medicines in onocology 2018-09-28
Bayer–Genedata: bioinformatics, 201809– license to Genedata Selector s/w for Bayer CropScience division for develop new fungicides 2018-09-27
BluCon Biotech–BRAIN: industrial biotechnology, 201809– strategic research collab microbial strain developm for PLA-based bioplastic 2018-09-18
Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification 2018-09-10
Merck (DE)–GlucoMe: digital health, 201808– collab digital diabetes management project in Vietnam 2018-08-22
SolasCure–BRAIN: investment, 201808 financing round Series A with participation of BRAIN at spin-off of SolasCure from BRAIN 2018-08-22
SolasCure–BRAIN: wound care product, 201808– license IP for Aurase enzyme + supply of enzymatic active ingredient by BRAIN to SolasCure 2018-08-22
Bayer–Haplogen: antiviral agents, 201808– collab €na developm candidates for pulmonary diseases incl COPD 2018-08-14
Miraca–Qiagen: molecular companion diagnostics, 201808– collab with SRL to introduce of CDx tests in Japan in line with respective drug approvals 2018-08-01
CeGaT–B Braun: investment, 201807 existent 30% shareholding of B Braun in CeGaT 2018-07-17
Labfolder–NEC: information technology, 201807– collab €na combining Labfolder s/w with NEC hardware for scalable data storage solutions 2018-07-17
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
BioNTech–Consilium: public relations, 201807 service existent international media relations + European IR by CSC 2018-07-10
BioNTech–Roivant: LNP technology, 201807– license excl to apply Genevant’s LNP delivery technology to 5 of BioNTech’s oncology programs 2018-07-10
BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic 2018-07-10
BioNTech–Westwicke Partners: public relations, 201807 service existent US IR by Westwicke Partners 2018-07-10
Roivant–BioNTech: mRNA therapeutics, 201807– collab strategic partnership to develop 5 products for rare disease with Genevant 2018-07-10
Boehringer–MabVax Therapeutics: antibody cancer drug, 201807 acquisition all rights to preclinical antibody program for solid tumours 2018-07-09
Evonik–BRAIN: industrial biotechnology, 201806– collab with CyPlus to develop products for global mining industry 2018-06-20
UgiSense–SEVERAL: investment, 201806 second financing round 2018-06-19
Univ Jena–Shimadzu: mass spectrometer, 201806 supply existent 2018-06-12
Evotec–Deutsche Bank: investor conference, 201806 supply service Evotec presents at dbAccess Berlin Conference 2018-06-07
Secarna–MC Services: public relations, 201806 service existent by MC Services 2018-06-04
High-Tech Gründerfonds–Bayer: investment, 201805 Bayer invests in HTGF III 2018-05-29
High-Tech Gründerfonds–Boehringer: investment, 201805 BIVF invests in HTGF III 2018-05-29
High-Tech Gründerfonds–SEVERAL: investment, 201805 2nd closing of HTGF III €71.5m bringing total fund size to €316.5m 2018-05-29
Acousia Therapeutics–Boehringer: investment, 201805 financing round Series B totalling €10m incl existing + co-investor BIVF 2018-05-14
Acousia Therapeutics–Creathor Venture: investment, 201805 financing round Series B totalling €10m incl new + co-investor Creathor Venture 2018-05-14
Acousia Therapeutics–Germany (govt): investment, 201805 financing round Series B totalling €10m incl existing + co-investor KfW 2018-05-14
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Bruker Corp–Deutsche Bank: investor conference, 201805 supply service Bruker presents at Deutsche Bank Annual Health Care Conference 2018-05-08
Waters–Deutsche Bank: investor conference, 201805 supply service Waters presents at Deutsche Bank 43rd Annual Health Care Conference in Boston 2018-05-08
Bruker Corp–CMS: legal services, 201805 service legal advice by CMS on acquisition of Sierra Sensors GmbH by Bruker 2018-05-06
Bruker Corp–CMS: legal services, 201808 service legal advice by CMS on majority acquisition of Hain Lifescience by Bruker 2018-05-06
Boehringer–Topas Therapeutics: immuno modulatory compounds, 201804– collab €na multi-y research + option agreem 2018-04-24
Merck (DE)–P&G: investment, 201804 acquisition €3.4b in cash of Merck’s consumer healthcare by P&G 2018-04-19
AiCuris–Max Planck: anti-infectives, 2018004– collab discovery of antibiotics + virostatic compounds extending existent collab with MPI-MP 2018-04-18
Boehringer–Biomax: bioinformatics, 201804– license multi-year for BioXM s/w + license extension for BioRS s/w 2018-04-10
Grünenthal–Univ Leuven: pain drugs, 201804– collab r+d non-opioid pain drugs with CD3 + LICR 2018-04-09
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Robert Bosch Hospital–bio.logis: genetic software, 201803– supply implementation of bio.logis GIMS IT platform at RBK 2018-03-20
Biocatalysts Ltd–BRAIN: investment, 201803 acquisition of majority stake in Biocatalysts Ltd by BRAIN AG 2018-03-17
Siemens–SEVERAL: investment, 201803 IPO €4.2b of Siemens Healthineers AG at FSE floating 150m (15% of) shares at €28/share 2018-03-16
Boehringer–Vanderbilt Univ: MCL1 inhibitors, 201803– collab expansion r+d of MCL1 inhibitors for cancer 2018-03-13
Danaher–KAUST: microscopy, 201803– collab establ KAUST-Leica Center of Excellence in Optical Microscopy 2018-03-12
ImmBioMed–Sekisui: coagulation tests, 201803 acquisiton of specialty coagulation assets of Sekisui Diagnostics GmbH by ImmBioMed 2018-03-12
KAUST–Danaher: microscopy, 201803 supply SP8 confocal platform to new KAUST-Leica Center of Excellence in Optical Microscopy 2018-03-12
Medical Univ Vienna–bio.logis: genetic software, 201803 collab use of bio.logis GIMS.DRM with safety code card at MUW 2018-03-12
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top